I agree, note holder was converting yesterday as well. They have a drug potential worth billions and a 150M market cap. If they can fix the dilutive financing problem, it will be a game changer for them. Interesting a new IH member joined a month ago said a deal was coming after a FDA meeting for combo and mono that no one know about. Turns out the FDA happened and then we have a possible deal announced. It will be interesting to see if he is correct on the deal. He said 2.3B.